首页> 外文会议>Annual meeting of the Controlled Release Society >INTRAOSSEOUS DELIVERY OF rhBMP-2/ HYALURONAN FOR OSTEOPOROSIS
【24h】

INTRAOSSEOUS DELIVERY OF rhBMP-2/ HYALURONAN FOR OSTEOPOROSIS

机译:骨髓内递送RHBMP-2 / Hyaluronan用于骨质疏松症

获取原文

摘要

rhBMP-2 was delivered from hyaluronan based materials formulated into solid depot rods for local intraosseous delivery to induce new bone formation. By varying dose and excipients, in vitro rhBMP-2 release was modulated to exhibit slow sustained release to fast burst release in bioactive form. In one formulation, in vivo release kinetics of the ~(125)I-rhBMP-2 / hyaluronan rods in rabbit distal femur intraosseous site revealed that rhBMP-2 was released to the local bone for over 10 weeks. Rat subcutaneous implants of the rhBMP-2 rods revealed bone formation in the surrounding tissue. These results indicate that local intraossesous delivery of rhBMP-2 may be a promising therapy for treatment of osteoporosis.
机译:RHBMP-2从配制成固体贮库棒的基于透明质酸的材料递送,用于局部骨质递送以诱导新的骨形成。通过改变剂量和赋形剂,调节体外RHBMP-2释放以表现出缓慢的持续释放,以在生物活性形式中快速爆裂释放。在一种制剂中,在兔远端股骨骨髓内部位于〜(125)I-RHBMP-2 /透明质酸杆的体内释放动力学显示出rhBMP-2释放到局部骨超过10周。 RHBMP-2棒的大鼠皮下植入物揭示了周围组织中的骨形成。这些结果表明,rhBMP-2的局部肿瘤递送可能是治疗骨质疏松症的有望的疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号